Literature DB >> 15936227

Venous leg ulcer: a meta-analysis of adjunctive therapy with micronized purified flavonoid fraction.

P Coleridge-Smith1, C Lok, A-A Ramelet.   

Abstract

OBJECTIVE: To assess the effect of oral treatment with micronized purified flavonoid fraction (MPFF) on leg ulcer healing.
DESIGN: Meta-analysis of randomised prospective studies using MPFF in addition to conventional treatment.
MATERIALS AND METHODS: Five prospective, randomised, controlled studies in which 723 patients with venous ulcers were treated between 1996 and 2001 were identified. Conventional treatment (compression and local care) in addition to MPFF was compared to conventional treatment plus placebo in two studies (N = 309), or with conventional treatment alone in three studies (N = 414). The primary end point was complete ulcer healing at 6 months.
RESULTS: At 6 months, the chance of healing ulcer was 32% better in patients treated with adjunctive MPFF than in those managed by conventional therapy alone (RRR: 32%; CI, 3-70%). This difference was present from month 2 (RRR: 44%; CI, 7-94%), and was associated with a shorter time to healing (16 versus 21 weeks; P = 0.0034). The main benefit of MPFF was present in the subgroup of ulcers between 5 and 10 cm2 in area (RRR: 40%; CI, 6-87%), and those present for 6-12 months duration (RRR: 44%; CI, 6-97%).
CONCLUSION: These results confirm that venous ulcer healing is accelerated by MPFF treatment. MPFF might be a useful adjunct to conventional therapy in large and long standing ulcers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936227     DOI: 10.1016/j.ejvs.2005.04.017

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  20 in total

Review 1.  Knowns and Unknowns in Managing Postthrombotic Syndrome.

Authors:  Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Ca(2+)-dependent contraction by the saponoside escin in rat vena cava: implications in venotonic treatment of varicose veins.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-04-16       Impact factor: 4.268

3.  Multifaceted management of the postthrombotic syndrome.

Authors:  Lina Nayak; Suresh Vedantham
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

4.  Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.

Authors:  Raffaele Serra; Raffaele Grande; Lucia Butrico; Gianluca Buffone; Francesco G Caliò; Aida Squillace; Barbara A Rizzo; Mafalda Massara; Francesco Spinelli; Alessia G Ferrarese; Giovanni de Caridi; Luca Gallelli; Stefano de Franciscis
Journal:  Int Wound J       Date:  2014-02-25       Impact factor: 3.315

Review 5.  Venous leg ulcers.

Authors:  E Andrea Nelson
Journal:  BMJ Clin Evid       Date:  2011-12-21

Review 6.  Endovascular Interventions for Acute and Chronic Lower Extremity Deep Venous Disease: State of the Art.

Authors:  Akhilesh K Sista; Suresh Vedantham; John A Kaufman; David C Madoff
Journal:  Radiology       Date:  2015-07       Impact factor: 11.105

Review 7.  Evidence-Based Clinical Practice Points for the Management of Venous Ulcers.

Authors:  Ravul Jindal; D B Dekiwadia; Pinjala Rama Krishna; Ajay K Khanna; Malay D Patel; Shoaib Padaria; Roy Varghese
Journal:  Indian J Surg       Date:  2018-01-27       Impact factor: 0.656

Review 8.  Venous leg ulcers.

Authors:  E Andrea Nelson; June Jones
Journal:  BMJ Clin Evid       Date:  2008-09-15

Review 9.  Neutrophil activity in chronic venous leg ulcers--a target for therapy?

Authors:  Jodi C McDaniel; Sashwati Roy; Traci A Wilgus
Journal:  Wound Repair Regen       Date:  2013-03-28       Impact factor: 3.617

Review 10.  Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review.

Authors:  Ke Xuan Li; Gisele Diendéré; Jean-Philippe Galanaud; Nada Mahjoub; Susan R Kahn
Journal:  Res Pract Thromb Haemost       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.